Efficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms.

Tae Wook KangJae Hung JungDong Wook KimKwang Ho LeeHyun Chul Chung

Published in: SAGE open medicine (2021)

We think tamsulosin monotherapy will be feasible as a first-line therapy for the patients with benign prostatic hyperplasia who has struggled with moderate-to-severe lower urinary tract symptoms.

Keyphrases

lower urinary tract symptoms
benign prostatic hyperplasia
combination therapy
high intensity
early onset
open label
drug induced
randomized controlled trial
clinical trial
study protocol